This is a working overview of receptor agonist, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-02-25 and is reviewed periodically as new material appears.
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.
Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.
Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C187H291N45O59 | Peptide backbone with a C18 fatty diacid side chain |
| Molecular weight | Approximately 4113 Da | Consistent with a 31-residue peptide plus linker |
| Appearance | White to off-white powder | Lyophilized solid; hygroscopic if left open |
| Solubility class | Sparingly soluble to soluble in water | Varies with pH and ionic strength |
| Typical analytical method | Reversed-phase HPLC with UV detection | Often paired with mass spectrometry for identity |
Development began in the early 2010s with the goal of extending GLP-1 activity beyond the brief window achieved by native peptide infusion. The earliest approved formulation was a subcutaneous injection given once weekly. A later oral tablet pairs the peptide with an absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, usually shortened to SNAC. That carrier lowers local pH and helps the peptide cross gastric tissue. Both routes deliver the same active molecule.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.
Serum protein binding dominates the pharmacokinetic profile. The attached chain associates strongly with albumin, shielding the peptide from enzymatic attack and slowing filtration by the kidney. This interaction extends the circulation half-life to roughly one week in humans, which supports weekly administration intervals. An oral version pairs the peptide with an absorption enhancer that transiently alters gastric epithelium, permitting limited uptake; bioavailability by that route is substantially lower than by injection.
Semaglutide belongs to the glucagon-like peptide-1 receptor agonist class, a group of synthetic peptides that imitate an incretin hormone released by intestinal L cells after food intake. Native GLP-1 circulates for only a few minutes because dipeptidyl peptidase-4 cleaves it rapidly. The hormone acts on pancreatic islets, the gastrointestinal tract, and several brain regions. Because the natural peptide is short-lived, development work concentrated on analogues that keep receptor activity while resisting enzymatic breakdown and renal clearance.
=== Fuel === Diethyl ether has a high cetane number of 85–96 and, in combination with petroleum distillates for gasoline and diesel engines, is used as a starting fluid because of its high volatility and low flash point. Ether starting fluid is sold and used in countries with cold climates, as it can help with cold starting an engine at sub-zero temperatures. For the same reason it is also used as a component of the fuel mixture for carbureted compression ignition model engines.
In 1953, Charles Frank proposed a model to demonstrate that homochirality is a consequence of autocatalysis. In his model the L and D enantiomers of a chiral molecule are autocatalytically produced from an achiral molecule A
Etonitazene, also known as EA-4941 or CS-4640, is a benzimidazole opioid, first reported in 1957, that has been shown to have approximately 1,000 to 1,500 times the potency of morphine in animals. Because it is characterized by a strong dependency potential and a tendency to produce profound respiratory depression, it is not used in humans. It is, however, useful in animal models for addiction studies, particularly those requiring the animals to drink or ingest the agent, because it is not as bitter as opiate salts like morphine sulfate.
== History == Pembrolizumab was invented by scientists at Organon after which they worked with Medical Research Council Technology (which became LifeArc) starting in 2006, to humanize the antibody; Schering-Plough acquired Organon in 2007, and Merck & Co. acquired Schering-Plough two years later. Inventors Gregory Carven, Hans van Eenennaam and Gradus Dulos were recognized as Inventors of the Year by the Intellectual Property Owners Education Foundation in 2016. The development program for pembrolizumab was seen as high priority at Organon, but low at Schering and later Merck. In early 2010, Merck terminated development and began preparing to out-license it. Later, in 2010, scientists from Bristol Myers Squibb published a paper in The New England Journal of Medicine showing that their checkpoint inhibitor, ipilimumab (Yervoy), had shown strong promise in treating metastatic melanoma and that a second Bristol Myers Squibb checkpoint inhibitor, nivolumab (Opdivo), was also promising. Merck at that time had little commitment or expertise in either oncology or immunotherapy, but understood the opportunity and reacted strongly, reactivating the program and filing its IND by the end of 2010. As one example, Martin Huber was one of the few senior people at Merck with strong experience in lung cancer drug development, but had been promoted to senior management and was no longer involved in product development. He stepped down from his role to lead clinical development of pembrolizumab for lung cancer.
Sources: en.wikipedia.org
=== Early professional organizations === The field began to organize under the name "clinical psychology" in 1917 with the founding of the American Association of Clinical Psychology. This organization lasted until 1919, after which the American Psychological Association (founded by G. Stanley Hall in 1892) developed a section on clinical psychology, which offered certification until 1927. Growth in the field was slow for the next few years until various unconnected psychological organizations came together as the American Association of Applied Psychology in 1937, which acted as the primary forum for psychologists until after World War II when the APA reorganized. In 1945, the APA created what is now called Division 12, the Society for Clinical Psychology, which remains a leading organization in the field. Psychological societies and associations in other English-speaking countries developed similar divisions, including those in Britain, Canada, Australia, and New Zealand.
==== Affinity-based peptide biosensors ==== This kind of peptide biosensor rely on peptides that can selectively bind a target like proteins, Small molecules, or ions. These peptides often mimic natural binding motifs, receptor fragments, antibody epitopes or ligand domains. They are engineered via methods such as phage display or computational design to achieve high affinity and specificity for their targets. These biosensors are widely used for detecting proteins, toxins and biomarkers due to affinity. Because affinity interactions offer great selectivity without requiring enzymatic reactions, these biosensors are frequently utilized for detecting proteins, toxins, and biomarkers.
Most proteins fold into unique 3D structures. The shape into which a protein naturally folds is known as its native conformation. Although many proteins can fold unassisted, simply through the chemical properties of their amino acids, others require the aid of molecular chaperones to fold into their native states. Biochemists often refer to four distinct aspects of a protein's structure:
Comb jellies, members of Ctenophora, are radially symmetric and have digestive chambers with a single opening, which serves as both mouth and anus. Ctenophora have distinct tissues, but these are not organised into discrete organs. They move using large arrays of cilia, called swimming plates. Almost all comb jellies are predatory. They have are unique in having colloblasts, structures on their tentacles that help them catch prey. They have nerve cells, but lack a brain or central nervous system. Instead their nerves are arranged into a nerve net. Their nerves are very different from those of other animals, and evidence suggests that their nerves developed independently of the nerves of other animals.
Around the elements in the middle of the periodic table, isotopes that are lighter than stable isotopes of the same element tend to decay through electron capture, while isotopes heavier than the stable ones decay by electron emission. Electron capture happens most often in the heavier neutron-deficient elements where the mass change is smallest and positron emission is not always possible. When the loss of mass in a nuclear reaction is greater than zero but less than 2mec2 the process cannot occur by positron emission, but occurs spontaneously for electron capture.
Sources: en.wikipedia.org
Things like ideologies, law, government, money and the economy are built on language; they exist because there are stories that billions of people believe. The current prevalence of misinformation suggests that an AI could use language to convince people to believe anything, even to take actions that are destructive. Geoffrey Hinton said in 2025 that modern AI is particularly "good at persuasion" and getting better all the time. He asks, "Suppose you wanted to invade the capital of the US. Do you have to go there and do it yourself? No. You just have to be good at persuasion." The opinions amongst experts and industry insiders are mixed, with sizeable fractions both concerned and unconcerned by risk from eventual superintelligent AI. Personalities such as Stephen Hawking, Bill Gates, and Elon Musk, as well as AI pioneers such as Geoffrey Hinton, Yoshua Bengio, Stuart Russell, Demis Hassabis, and Sam Altman, have expressed concerns about existential risk from AI. In May 2023, Geoffrey Hinton announced his resignation from Google in order to be able to "freely speak out about the risks of AI" without "considering how this impacts Google". He notably mentioned risks of an AI takeover, and stressed that in order to avoid the worst outcomes, establishing safety guidelines will require cooperation among those competing in use of AI. In 2023, many leading AI experts endorsed the joint statement that "Mitigating the risk of extinction from AI should be a global priority alongside other societal-scale risks such as pandemics and nuclear war".
Denmark is one of the twelve original founding member states of NATO, and signed the Greenland Defense Agreement with the United States in 1951, allowing the American military to operate in Greenland with Danish consent under a NATO framework. At its peak, approximately 10,000 American military personnel were stationed in Greenland, including about 6,000 at what is now Pituffik Space Base. After the Cold War, Greenland became a lower strategic priority for the United States, which gradually reduced its presence to roughly 150 personnel by 2026. After the September 11 attacks in 2001, Denmark supplied military aid to the United States as part of its NATO Article 5 obligation, incurring 44 deaths in the Afghan War. Denmark increased its Arctic defence and led a large NATO exercise in Greenland in 2025. The exercise involved more than 550 soldiers, including special forces, from Denmark, Norway, Sweden, France, and Germany. The Nordic countries also collaborate on Arctic defence through NATO exercises conducted across the region, such as the Joint Viking exercise in 2025. In 2025, Denmark announced a 14.6 billion kr. plan to boost Arctic defence. Greenland is under the military command of the Joint Arctic Commander, Danish general Søren Andersen. The Arctic Command has around 150 permanent personnel, but regularly deploys units from across the Danish Defence forces, including the Arctic Response Force with aircraft and ships that stand ready to support forces in Greenland.
=== Role in tissue homeostasis === Every tissue harbors its own specialized population of resident macrophages, which entertain reciprocal interconnections with the stroma and functional tissue. These resident macrophages are sessile (non-migratory), provide essential growth factors to support the physiological function of the tissue (e.g. macrophage-neuronal crosstalk in the guts), and can actively protect the tissue from inflammatory damage.
This stress response indirectly improves the antioxidant capacity of the cell. The (S)-enantiomer of LA was shown to be toxic when administered to thiamine-deficient rats. Several studies have demonstrated that SLA either has lower activity than RLA or interferes with the specific effects of RLA by competitive inhibition.
==== Memorial ceremony for the Martyrs of San Juan de Wilson ==== At 6:30pm on March 5, 1870, San Andrés Lodge No. 3, in Havana, held a memorial ceremony to observe Masonic funeral rites for the deceased Grand Master Andrés Puente. Despite the fact that certain members of the Lodge were afraid that a memorial gathering would put their lives in danger, nevertheless more than 100 people made a fully-packed temple that night, with all Lodge members present. The local police, however, had also known that there would be a memorial that night. When the temple was full, the armed and uniformed police mustered in the street out front of the Lodge. As the police were getting into formation, local citizens gathered behind them and grew into a large mob, chanting and crying out: "Kill the conspirators, death to the Cuban Council!" When the police breached the building, the Outside Guard informed Worshipful Master Nicolas Dominguez Cowan that the police were on the stairs. Cowan addressed the Freemasons: "Do not be alarmed, my dear brethren, our fate, whatever it may be, we must face with courage; we must save our charter above everything else." Edward Godwin, a government employee at the local customs house, escaped the Lodge with the charter and brought it to the safety at a house belonging to another Freemason, where he stashed it. Of the over 100 people in the building that night, over 40 of them were arrested and taken to prison. Some of the members were able to evade capture. Those forty or more Freemasons who were arrested that night were imprisoned for one hundred days.
Sources: en.wikipedia.org
It is given either as a once-weekly subcutaneous injection or as an oral tablet taken once daily. The two forms use different absorption strategies, so they are not interchangeable on a milligram-for-milligram basis.
Structural modifications, including a fatty acid side chain and non-natural amino acid substitutions, slow enzymatic breakdown and promote albumin binding. These changes support once-weekly dosing rather than twice-daily administration.
The pathways involving insulin, glucagon, gastric emptying, and appetite signaling are well described. How much each pathway contributes to weight reduction in a given person is not fully established.
Native GLP-1 is a short-lived peptide cleared within one to two minutes by dipeptidyl peptidase-4 and related enzymes. Semaglutide keeps the receptor-binding backbone but adds substitutions and a lipid chain. These changes block the main cleavage site and allow reversible albumin binding, extending the half-life to roughly 165 hours.